Total symptom score was higher for patients without deep reflux both pre (median, 14, [IQR,(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)] vs median 13.5 [IQR, 9.5-18.0]; P ¼ .005) and postprocedurally (median, 4 [IQR,(1)(2)(3)(4)(5)(6)(7)(8)(9) vs median 3.25 [IQR, 1-7]; P < .001) but no difference was seen in change in symptom score (median, 8 [IQR,(4)(5)(6)(7)(8)(9)(10)(11)(12)(13) vs median 9 [IQR, 4-13]; P ¼ .172). Patients with deep reflux had substantially higher rates of complications (10.4% vs 3.0%; P < .001) with a particular increase in proximal thrombus extension (3.1% vs 1.1%; P < .001). After controlling for confounding, this estimate of effect size for any complication increased (OR, 5.72; 95% CI, 2.21-14.81; P < .001).Conclusions: No significant difference is seen in total symptom improvement when patients undergo truncal endovenous ablation with concomitant deep venous reflux, although a greater improvement was seen in VCSS score in these patients. Patients with deep venous reflux had a significantly increased rate of complications independent of confounding variables and should be counseled appropriately before the decision for treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.